Stay updated on AEB1102 in Arginase I Deficiency Clinical Trial
Sign up to get notified when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.

Latest updates to the AEB1102 in Arginase I Deficiency Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase 1/2 study for Arginase I Deficiency and the addition of a new revision number. The name of the drug AEB1102 remains, but the context surrounding its study has been largely deleted.SummaryDifference22%
- Check44 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check87 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check102 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check109 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to AEB1102 in Arginase I Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.